Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Strain Specific Effects of Probiotic Supplementation on Serum Amino Acid Profiles in Alzheimer’S Disease: A Randomized, Double Blind, Placebo Controlled Trial Publisher Pubmed



N Jouni NAGHAM ; C Akhgarjand CAMELLIA ; Zs Vahabi Zahra SYAVASH ; S Shabbidar SAKINEH ; H Khalifeh HALA ; K Djafarian KUROSH
Authors

Source: Scientific Reports Published:2025


Abstract

Alzheimer’s disease (AD) is a neurodegenerative condition characterized by cognitive decline and associated metabolic disturbances, including altered amino acid profiles. This study investigated the effects of probiotic supplementation with Lactobacillus rhamnosus HA-114 and Bifidobacterium longum R0175 on serum amino acid levels in adults with mild to moderate AD. In a 12-week, randomized, double-blind, placebo-controlled trial, 60 participants (aged 50–90 years) were assigned to three groups: L. rhamnosus (n = 20), B. longum (n = 20), or placebo (n = 20). Serum amino acids were analyzed using High-Performance Liquid Chromatography (LC). Changes in total amino acids, Branched Chain Amino Acids (BCAAs), and aromatic amino acids (AAAs) were assessed as the primary outcomes. A significant interaction effect was found between time and group for serum amino acids. Compared to placebo, the B. longum group showed a significant increase in total amino acids (difference: 2132.67 µmol/L, 95% CI: 464.06–3801.28; p = 0.01), BCAAs (difference: 255.15 µmol/L, 95% CI: 53.01–457.30; p = 0.01), and AAAs (difference: 374.34 ng/ml, 95% CI: 57.45–691.23; p = 0.02). The L. rhamnosus group also showed a significant increase in BCAAs compared to placebo (difference: 206.08 µmol/L, 95% CI: 3.94–408.23; p = 0.04). The greatest improvements were consistently observed in the B. longum group across all primary outcome measures. Probiotic supplementation, particularly with B. longum, significantly improved serum amino acid profiles in patients with mild to moderate Alzheimer’s disease. These findings support the potential of specific probiotic strains to address metabolic imbalances in AD through gut-brain axis modulation. Trial Registration: IRCT number: 20210513051277N1 (2021-05-27). © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. The Effects of Probiotic Supplements on Oxidative Stress and Inflammation in Subjects With Mild and Moderate Alzheimer’S Disease: A Randomized, Double-Blind, Placebo-Controlled Study, Inflammopharmacology (2024)
2. Effects of Probiotic Supplements on Cognition, Anxiety, and Physical Activity in Subjects With Mild and Moderate Alzheimer’S Disease: A Randomized, Double-Blind, and Placebo-Controlled Study, Frontiers in Aging Neuroscience (2022)
3. Synbiotic Supplementation and Its Effects on Cognition in Alzheimer's Patients: A Double-Blind Study, Basic and Clinical Neuroscience (2024)
Experts (# of related papers)
View all Related Experts
Zahra Vahabi (4)
Farnaz Etesam (2)
Other Related Docs
4. The Interplay Between Gut Microbiota Composition and Dementia, Reviews in the Neurosciences (2025)
5. Neuroprotective Effects of Probiotics Bacteria on Animal Model of Parkinson’S Disease Induced by 6-Hydroxydopamine: A Behavioral, Biochemical, and Histological Study, Journal of Immunoassay and Immunochemistry (2021)
6. Impact of Probiotic Supplementation on Serum Levels of Brain-Derived Neurotrophic Factor: Grade-Based Dose-Response Meta-Analysis, BMC Nutrition (2025)
7. Clinical and Metabolic Response to Probiotic Administration in Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial, Nutrition (2016)
8. Lactobacilli and Bifidobacteria Ameliorate Memory and Learning Deficits and Oxidative Stress in Β-Amyloid (1–42) Injected Rats, Applied Physiology# Nutrition and Metabolism (2018)
9. The Role of Intestinal Microbiota in Cognitive Disorders, Journal of Mazandaran University of Medical Sciences (2021)
10. The Effects of Spirulina Intake on Clinical and Metabolic Parameters in Alzheimer's Disease: A Randomized, Double-Blind, Controlled Trial, Phytotherapy Research (2023)
11. Association Between Animal Protein Sources and Risk of Neurodegenerative Diseases: A Systematic Review and Dose-Response Meta-Analysis, Nutrition Reviews (2023)
12. The Relationship Between Micronutrients and Cognitive Ability in an Elderly Population With Mild Cognitive Impairment and Alzheimer’S Disease: A Cross-Sectional Study, BMC Neurology (2024)
13. Assessment of Probiotics Mixture on Memory Function, Inflammation Markers, and Oxidative Stress in an Alzheimer's Disease Model of Rats, Iranian Biomedical Journal (2020)
14. Probiotics Improve Insulin Resistance Status in an Experimental Model of Alzheimer's Disease, Medical Journal of the Islamic Republic of Iran (2017)
15. Is There Any Link Between Cognitive Impairment and Gut Microbiota? a Systematic Review, Gerontology (2022)
16. Amino Acid Patterns Predict White Matter Integrity Measures in the Brain in Patients Across the Alzheimer’S Disease Continuum, Metabolic Brain Disease (2025)
17. Exploring the Effect of Gut Microbiome on Alzheimer's Disease, Biochemistry and Biophysics Reports (2024)
18. The Effects of Probiotic Supplementation on Metabolic Status in Type 2 Diabetic Patients With Coronary Heart Disease Irct2017082733941n5 Irct, Diabetology and Metabolic Syndrome (2018)
19. Csf Amino Acid Profiles in Icv-Streptozotocin-Induced Sporadic Alzheimer's Disease in Male Wistar Rat: A Metabolomics and Systems Biology Perspective, FEBS Open Bio (2024)
20. Gut Microbiota Depletion From Early Adolescence Alters Anxiety and Depression-Related Behaviours in Male Mice With Alzheimer-Like Disease, Scientific Reports (2021)